CClinicalTrials.gg
CompletedNCT02911181Updated Sep 22, 2016

Quality Project Malnutrition Intensive Care

An observational study in Malnutrition, sponsored by Medical Centre Leeuwarden. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-09-22.

Sponsored by Medical Centre Leeuwarden · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

Observational study to investigate nutrition state in all admitted patients in ICU. Measurement by BIVA and SNAQ score.

Read the detailed description

Malnutrition is a great problem in healthcare, its related to mortality, infections and length of stay. Observational study to investigate nutrition state in all admitted patients in ICU. Measurement by BIVA and SNAQ score.

All patients were asked for their nutrition state by SNAQ and the BIVA measurement is done by a trained doctor.

02

Conditions studied

  • Malnutrition

Browse trials for

Keywords

  • BIVA measurement
  • SNAQ score
03

In context

Malnutrition

1,587 studies on the registry are indexed under Malnutrition; 237 are open to participants now.

This study's enrollment of 300 is above the median of 203 across 388 observational studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

Medical Centre Leeuwarden is the lead sponsor of 41 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients admitted in the ICU between feb 2016 and may 2016

Inclusion criteria

  • admission ICU

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (actual)
Patient registry
No

Interventions

  • OtherBIVA measurement
06

What researchers measure

Primary outcomes

  1. malnutrition

    percentage of patients with malnutrition at admission on the ICU

    Time frame: day 1 in Intensive Care

Secondary outcomes

  1. malnutrition in elective and acute patients

    Is there a difference in malnutrition between elective patients and acute patients

    Time frame: day 1 in Intensive Care

07

Study locations

1 site
  • Medical Centre Leeuwarden
    Leeuwarden, Netherlands
08

References and documents

Publications

  • Buter H, Veenstra JA, Koopmans M, Boerma CE. Phase angle is related to outcome after ICU admission; an observational study. Clin Nutr ESPEN. 2018 Feb;23:61-66. doi: 10.1016/j.clnesp.2017.12.008. Epub 2017 Dec 20. PubMed 29460815 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02911181
Lead sponsor
Medical Centre Leeuwarden
Responsible party
Matty Koopmans (MSc, Medical Centre Leeuwarden) — Principal investigator
First posted
Sep 22, 2016
Start date
Feb 2016
Primary completion
Jun 2016
Completion
Sep 2016
Last update
Sep 22, 2016

Study contacts

Matty Koopmans, MSc
principal investigator · Intensive Care

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion